CMS Modifies TENS Coverage for Chronic Low Back Pain: What Billing Teams Need to Know About NCD 354

The Centers for Medicare & Medicaid Services has modified National Coverage Determination (NCD) 354, governing Transcutaneous Electrical Nerve Stimulation (TENS) for chronic low back pain (CLBP). This update directly affects how Medicare bills for TENS devices under the Durable Medical Equipment (DME) benefit category — and the coverage restrictions are significant. If your practice or DME supplier provides TENS therapy to Medicare beneficiaries with CLBP, this policy change should trigger an immediate review of your billing protocols.

CMS TENS Coverage for Chronic Low Back Pain: What NCD 354 Actually Says

The core issue with NCD 354 is that CMS coverage for TENS in CLBP is not routine coverage — it's a Coverage with Evidence Development (CED) policy. That distinction matters enormously for billing.

Under CED, Medicare will only pay for TENS in CLBP patients when the beneficiary is enrolled in an approved clinical study. This isn't a technicality buried in the policy. It's the primary coverage condition. If a patient is not enrolled in a qualifying randomized, controlled trial, the claim will not be covered — full stop.

CMS originally published this decision with an explicit sunset clause: coverage under the CED framework expires three years after publication. Billing teams should be tracking that expiration date as a hard deadline for any active TENS orders tied to clinical study enrollment.

How CMS Defines "Chronic Low Back Pain" Under NCD 354

Before you can evaluate whether a claim is billable, your team needs to confirm the patient actually meets CMS's definition of CLBP. The policy is specific on two points:

1. The episode of low back pain must have persisted for three months or longer
2. The pain must not be a manifestation of a clearly defined primary disease entity

That second criterion is where denials can sneak up on you. CMS explicitly calls out conditions like metastatic cancer spreading to the spine or pelvis, rheumatoid arthritis, and multiple sclerosis. If the low back pain is a symptom of one of these underlying conditions — rather than a standalone diagnosis — the patient does not qualify under this NCD. Document carefully in the chart that the treating clinician has ruled out a primary disease etiology.

The Clinical Study Requirement: What Qualifies Under NCD 354

This is where NCD 354 gets operationally complex. Medicare coverage only applies when the beneficiary is enrolled in a study designed to answer at least one of the following questions:

The study design must be randomized and controlled, using validated and reliable instruments. Randomized crossover designs are permitted, but only when prior TENS exposure is appropriately accounted for in the study protocol. Control and comparison groups must receive identical concurrent treatments alongside either sham (placebo) TENS or active TENS.

The study itself must meet a rigorous set of standards — it must have a principal purpose of testing health outcomes, align with available scientific evidence, avoid unjustifiable duplication of existing research, and comply with federal human subjects protections under 45 CFR Part 46. If the study is FDA-regulated, compliance with 21 CFR Parts 50 and 56 is also required.

For billing teams, this means you need documentation on file confirming the patient's enrollment in a specific approved study before submitting a claim.

TENS as a DME Benefit: Billing Category Considerations

CMS classifies TENS under the Durable Medical Equipment benefit category. That classification matters for which Medicare contractor processes the claim and what documentation standards apply.

TENS devices may be used in multiple settings — the patient's home, a physician's office, or an outpatient clinic — and the policy notes that payment may be made under the DME benefit regardless of setting. However, the CED enrollment requirement doesn't change based on setting. A TENS unit used at home by a Medicare CLBP patient without active clinical study enrollment is not covered under NCD 354.

Affected Codes

The policy data for NCD 354 does not list specific CPT or HCPCS codes. Billing teams should contact their Medicare Administrative Contractor (MAC) directly to confirm which HCPCS codes for TENS devices are applicable under the DME benefit category in their jurisdiction, and cross-reference the LCD (Local Coverage Determination) that may supplement this NCD in their region.

Related ICD-10 Diagnosis Codes — While the policy does not enumerate specific codes, the CLBP definition in NCD 354 aligns with the following diagnosis codes. Confirm appropriate code selection with your coding team:

Note: Codes for low back pain secondary to a primary disease entity (e.g., metastatic neoplasm, rheumatoid arthritis) would not satisfy the CLBP definition under NCD 354 and should not be used to support TENS coverage.

What Your Billing Team Should Do